Page last updated: 2024-11-04

rofecoxib and Genetic Diseases, X-Chromosome Linked

rofecoxib has been researched along with Genetic Diseases, X-Chromosome Linked in 1 studies

Research Excerpts

ExcerptRelevanceReference
"He had been diagnosed clinically with nephrogenic diabetes insipidus and treated by amiloride and hydrochlorothiazide combination without a satisfactory outcome at another center since 1 year of age."1.33Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus. ( Hoefsloot, L; Kasap, B; Kavukçu, S; Oğün, N; Oztürk, Y; Soylu, A; Türkmen, M, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soylu, A1
Kasap, B1
Oğün, N1
Oztürk, Y1
Türkmen, M1
Hoefsloot, L1
Kavukçu, S1

Other Studies

1 other study available for rofecoxib and Genetic Diseases, X-Chromosome Linked

ArticleYear
Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus.
    Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:12

    Topics: Amiloride; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Insipidus, Nephrogenic; Diuretics

2005